Filing Details
- Accession Number:
- 0001209191-23-058899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-15 21:00:12
- Reporting Period:
- 2023-12-14
- Accepted Time:
- 2023-12-15 21:00:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674282 | Michael Castagna | 1 Casper Street Danbury CT 06810 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Disposition | 2023-12-14 | 10,000 | $4.00 | 2,339,147 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2023-12-14 | 100,000 | $4.00 | 2,239,147 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2023-12-15 | 90,482 | $4.00 | 2,148,665 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction occurred pursuant to Rule 10B5-1 Plan established December 19, 2022. All transactions contemplated by such plan have now been completed.
- Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023.
- Transaction occurred pursuant to Rule 10B5-1 Plan established September 1, 2023. All transactions contemplated by such plan have now been completed.